Ursula Jeffry

514 total citations
10 papers, 207 citations indexed

About

Ursula Jeffry is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Ursula Jeffry has authored 10 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 4 papers in Molecular Biology. Recurrent topics in Ursula Jeffry's work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ursula Jeffry is often cited by papers focused on CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Ursula Jeffry collaborates with scholars based in United States, Netherlands and Switzerland. Ursula Jeffry's co-authors include Richard Murray, Ada M. Kruisbeek, Mariëtte A. Oosterwegel, Ian Kasman, Alberto Rissone, Anette Magnussen, Patricia Parsons‐Wingerter, Scott M. Norberg, Sara Zanivan and Donald M. McDonald and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

Ursula Jeffry

9 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ursula Jeffry United States 5 96 90 48 40 24 10 207
Kathrin Gollmer Switzerland 7 139 1.4× 91 1.0× 75 1.6× 40 1.0× 6 0.3× 11 235
George A. Dominguez United States 5 198 2.1× 73 0.8× 126 2.6× 27 0.7× 7 0.3× 12 279
Ann-Sofie Hansson Sweden 6 88 0.9× 32 0.4× 23 0.5× 35 0.9× 32 1.3× 7 264
Salah Almokadem United States 5 36 0.4× 67 0.7× 73 1.5× 66 1.6× 11 0.5× 9 154
Evelina Poletto Italy 9 53 0.6× 118 1.3× 65 1.4× 32 0.8× 10 0.4× 12 220
Hideki Mitsui Japan 11 130 1.4× 132 1.5× 53 1.1× 70 1.8× 18 0.8× 17 340
Catherine A. Eberlein United Kingdom 4 27 0.3× 69 0.8× 74 1.5× 46 1.1× 15 0.6× 4 149
Sophie Duchez France 9 218 2.3× 90 1.0× 55 1.1× 34 0.8× 46 1.9× 12 316
Kamil Jastrzębski Poland 11 103 1.1× 169 1.9× 49 1.0× 24 0.6× 19 0.8× 13 303
Ning Lu Yoshida Japan 7 138 1.4× 99 1.1× 46 1.0× 41 1.0× 7 0.3× 9 242

Countries citing papers authored by Ursula Jeffry

Since Specialization
Citations

This map shows the geographic impact of Ursula Jeffry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Jeffry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Jeffry more than expected).

Fields of papers citing papers by Ursula Jeffry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Jeffry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Jeffry. The network helps show where Ursula Jeffry may publish in the future.

Co-authorship network of co-authors of Ursula Jeffry

This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Jeffry. A scholar is included among the top collaborators of Ursula Jeffry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ursula Jeffry. Ursula Jeffry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Xiang, Hong, Ago Ahene, David I. Bellovin, et al.. (2021). Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer. mAbs. 13(1). 1981202–1981202. 26 indexed citations
3.
Hsu, Amy, Hong Xiang, Ago Ahene, et al.. (2017). FPA150, a novel B7-H4 therapeutic antibody with checkpoint blockade and ADCC activities. Annals of Oncology. 28. v2–v2. 2 indexed citations
4.
Wiesmann, Marion, Dylan Daniel, Nancy Pryer, et al.. (2010). Abstract 3629: BLZ945, a selective c-fms (CSF-1R) kinase inhibitor for the suppression of tumor-induced osteolytic lesions in bone. Cancer Research. 70(8_Supplement). 3629–3629. 9 indexed citations
5.
Pryer, Nancy, Victoria Sung, Ursula Jeffry, et al.. (2009). Abstract #DDT02-2: MCS110: a monoclonal antibody with potent neutralizing activity against macrophage colony-stimulating factor for the treatment of tumor-induced osteolysis. Cancer Research. 69. 1 indexed citations
6.
Parsons‐Wingerter, Patricia, Ian Kasman, Scott M. Norberg, et al.. (2005). Uniform Overexpression and Rapid Accessibility of α5β1 Integrin on Blood Vessels in Tumors. American Journal Of Pathology. 167(1). 193–211. 70 indexed citations
7.
Ramakrishnan, Vanitha, Vinay Bhaskar, Debbie A. Law, et al.. (2004). M200, an integrin α5β1 antibody, promotes apoptosis in proliferating endothelial cells. Journal of Clinical Oncology. 22(14_suppl). 3187–3187. 2 indexed citations
8.
9.
Jeffry, Ursula, Kay Huh, Tong Xia, et al.. (2004). Safety Evaluation of an Fully Human Antagonist Anti-CD40 Antibody, CHIR-12.12, in a Dose Range-Finding Study in Cynomolgus Monkeys.. Blood. 104(11). 3282–3282. 5 indexed citations
10.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathrin Gollmer Breakdown of academic impact, for papers by George A. Dominguez Breakdown of academic impact, for papers by Ann-Sofie Hansson Breakdown of academic impact, for papers by Salah Almokadem Breakdown of academic impact, for papers by Evelina Poletto Breakdown of academic impact, for papers by Hideki Mitsui Breakdown of academic impact, for papers by Catherine A. Eberlein Breakdown of academic impact, for papers by Sophie Duchez Breakdown of academic impact, for papers by Kamil Jastrzębski Breakdown of academic impact, for papers by Ning Lu Yoshida
Rankless by CCL
2026